The collaboration arrives at a critical moment when pharmaceutical companies are racing to adopt AI but wrestle with unprecedented volumes of complex scientific data, much of it locked in proprietary ...
Building on these foundational components of our program, we have devoted significant resources to implementing the EU AI Act across Microsoft. Cross-functional working groups combining AI governance, ...